About PSA
Corrections
PSA corrects errors of fact promptly and visibly. Each correction below also appears as a dated note on the story itself. To request a correction, use the form below or email Jack@psychedelicamericas.org. Our full policy is on our Editorial Standards page.
November 9, 2026
- "Psychedelic VC Steve Jurvetson Mentioned in FBI Memo Found in Epstein Files" (November 9, 2026). A second, uncorrected copy of this story was sent by email on February 3. That copy did not include Mr. Jurvetson's response or our February 9 correction. It was never published on our website, and we have retired it. In the corrected story, we fixed references to "DFJ Capital," which should have read "DFJ." We also corrected our description of Charles Lieber: he was convicted of making false statements and of tax offenses, not espionage. We also revised the story's subheadline and search description to match its corrected title.
November 8, 2026
- "With Psilocybin Doses Projected Up to $22,000, Usona and Compass Race Toward FDA Approval" (November 8, 2026). The per-dose range is PSA's own calculation from Compass's stated annual target of $50,000 to $65,000 and an assumed three doses a year. The story gave the range as $18,000 to $22,000. That math gives about $17,000 to $22,000, and the story now says so and attributes the calculation to PSA.
October 23, 2026
- "Small Study Explores Psilocybin's Effects on Inflammation-Linked Signals in Parkinson's Disease" (October 23, 2026). The original headline said psilocybin "addresses strong inflammatory signals," and the subheadline said the findings "could likely help treat other diseases." The study was small and open-label, with no control group, and does not support either claim. We revised both.
August 25, 2026
- "Survey Links Psychedelic Decriminalization to Perceived Wellbeing and Reduced Harm" (August 25, 2026). The original headline presented findings from a survey of perceptions as if they were measured outcomes. We revised the headline.
February 9, 2026
- "Psychedelic VC Steve Jurvetson Mentioned in FBI Memo Found in Epstein Files" (February 9, 2026). Updated February 9, 2026, with Mr. Jurvetson's response.
January 25, 2026
- "NJ Psilocybin Legislation Exposes Conflicts Between Advocates for Different Therapeutic Models" (January 25, 2026). A quote was withdrawn at the source's request after publication. The story carries an update note.
Request a correction
Spotted an error? Tell us which story and what's wrong. Our editors review every request.